Dr. Agarwal's Health Care Limited
NSE: AGARWALEYEINE943P01029·HealthcareMicrocap 250·www.dragarwals.co.in ↗·Mcap ₹15,713 Cr·Listed 2025
₹500.00▼ ₹2.10  (−0.42%)
52W: ₹401 – ₹568 · Vol: 2.4L shares · Close 25 Sept
Set Alert

Quarterly results

consolidated · as filed with NSE · Q1 FY27 back to Q3 FY25
₹ croreQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25
Revenue from operations614564530499487460431
Other income6.412.610.57.913.415.412.7
Total expenses545501476453447415402
EBITDA170161144136128131115
EBITDA margin27.8%28.6%27.2%27.3%26.2%28.5%26.7%
Finance costs23.422.121.122.624.72528.4
Depreciation78.376.768.867.96360.458.2
Profit before tax75.176.664.853.753.658.541
Tax20.126.721.117.215.51612.8
Net profit555043.636.538.142.628.2
Net margin9.0%8.9%8.2%7.3%7.8%9.2%6.6%
EPS (₹)1.431.251.070.940.951.040.73
Net profit YoY+44.6%+17.4%+54.5%––––

Annual results

financial years ending March · from the fourth-quarter filings
₹ croreFY26FY25
Revenue from operations2,0801,711
Other income44.446
Total expenses1,8771,594
EBITDA570456
EBITDA margin27.4%26.7%
Finance costs90.5109
Depreciation276231
Profit before tax249160
Tax80.549.5
Net profit168110
Net margin8.1%6.4%
EPS (₹)4.212.80
Net profit YoY+52.4%–
EPS is as filed for each period and is not restated for later bonus issues or splits.

Cash flow

annual · ₹ crore
₹ croreFY26FY25
Operating cash flow519360
Investing cash flow−308−750
Financing cash flow−220382
Capital expenditure448309
Free cash flow (CFO − capex)7151.7

Net profit trend

annual, ₹ crore
FY25
₹110
FY26
₹168+52%

Result filings

as filed with NSE · PDF and XBRL
PeriodBasisFiledDocuments
Q1 FY27Consolidated4 Aug 2026PDF on NSE XBRL
Q1 FY27Standalone4 Aug 2026PDF on NSE XBRL
Q4 FY26Consolidated · audited21 May 2026PDF on NSE XBRL
Q4 FY26Standalone · audited21 May 2026PDF on NSE XBRL
Q3 FY26Consolidated3 Feb 2026PDF on NSE XBRL
Q3 FY26Standalone3 Feb 2026PDF on NSE XBRL
Q2 FY26Consolidated30 Oct 2025PDF on NSE XBRL
Q2 FY26Standalone30 Oct 2025PDF on NSE XBRL
Q1 FY26Consolidated12 Aug 2025PDF on NSE XBRL
Q1 FY26Standalone12 Aug 2025PDF on NSE XBRL

Annual reports

NSE archive
Key ratios
P/E (TTM)5Y avg 102.3×85.6×
P/B5Y avg 7.42×7.82×
ROEFY26, on average equity8.6%
Net margin8.1%
Debt / equity0.08×
Revenue CAGR (3Y)–
Profit CAGR (3Y)–
EPS (TTM)₹5.84
Market cap₹15,840 Cr
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.
P/B vs history
7.82×
vs 3-point avg 7.42× (+5%)
6.36× low7.42× avg8.32× high
History points are balance-sheet dates (2025 → 2026), priced at the adjusted close on each date.
Balance sheet 31 Mar 2026
Total assets₹3,942 Cr+7%
Net worth₹2,025 Cr+9%
Total borrowings₹157 Cr−36%
Cash & bank balances₹91 Cr−13%
Investments₹152 Cr−42%
Inventories₹94 Cr+17%
Trade receivables₹161 Cr+30%
Trade payables₹149 Cr−2%
Change vs the same date a year earlier.
Shareholding 30 Jun 2026
%Jun 26Mar 26Dec 25Sept 25Jun 25Mar 25Feb 25
Promoter32.3432.3632.3932.4232.4232.4532.45
FII57.9657.9458.0658.1359.2660.6256.97
DII7.727.837.787.926.445.215.10
of which MF6.025.875.775.854.91––
Retail1.811.681.621.411.741.624.80
Other public0.170.190.150.120.140.100.68
42,492 shareholders · NSE shareholding pattern filings.